Search
Press release
Press
January 10, 2020

Evonik strengthens its focus on adhesive and sealant solutions with a new multi-purpose silicone production facility in Geesthacht, Germany

  • Double-digit million euro state-of-the-art investment project completed on time and within budget
  • New silicones manufacturing facility expands capacities and allows production flexibility for increased innovation
  • Evonik reinforces its focus on innovative specialty chemical products for silicone and nanotechnologies including new logistical solutions

10th January-Geesthacht/Essen, Germany. Following its double-digit million euro investment and after less than 18 months of construction, Evonik officially opened its new multi-purpose silicones manufacturing facility in Geesthacht, Germany. A celebratory inauguration ceremony was held at the site on 10th January and attended by local dignitaries, including the Mayor of Geesthacht, Evonik’s construction partners and its staff.

Located in Northern Germany, 30 kilometers outside the port city of Hamburg, the new plant was completed on time and within the planned budget. Commissioning of the facility’s new tank farm started in December and incremental production increases are planned over the coming months. “I’m delighted to open our new facility and continue the long history of production at the site, said Dr. Xiaolan Wang, head of the Interface & Performance Business Line of Evonik. The increased production footprint helps to strengthen our focus on silicone and nanotechnology specialty chemical products, while also providing our customers with a faster, more reliable supply of the products they need.”

There has now almost been 35 years of continuous chemical production at the site, producing high-quality components and raw materials for the manufacture of sealants and adhesives, molding and casting compounds, and other products.

Standing on the same site as the existing plant, the new tank farm had to be built and commissioned for use while keeping production running smoothly for Evonik’s customers. The additional capacities are for a range of silicone and nanotechnology products. These include: addition-curing silicones and silyl-terminated polymers which are used as binders for adhesives and sealants in parquet adhesives, adhesives for wound care and other medical applications or in electronics such as e-mobility housings or potting materials.

To address the increasing market requirements a broad range of silyl-terminated polymers (SMP‘s) will also be produced. “The other advantage of creating more room and flexibility in our production schedule is that we can react quickly to changing market demands, as well as develop new products”, said Dr. Sabine Giessler-Blank, head of the Polymer & Construction Specialties Product Line. “Our customers rely on us to innovate and deliver property-enhancing products, for example developing SMP‘s to address the trend for roofing and liquid membranes, or help them to meet the growing demand for strong, but lightweight fiber composite applications in the automotive and aerospace industries.”

In addition to the increased capacity, a new tank truck filling facility has been completed at the site. By simplifying the delivery and storage process for customers Evonik hopes to also increase efficiency in this process as well.

Foto caption: Left to right: Olaf Schulze, Mayor of Geesthacht, Lauren Kjeldsen, Managing Director Evonik Nutrition & Care, Mathias Jammer, Site Manager Geesthacht

Company information

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.

About Nutrition & Care GmbH

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around
€4.6 billion in 2018.

Disclaimer

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.